Communication of positive newborn screening results for sickle cell disease and sickle cell trait: Variation across states

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 148, Issue 1, 2008, Pages 15-22

  Kavanagh, Patricia L ^a   Wang, C Jason ^b,c   Therrell, Bradford L ^d,e   Sprinz, Philippa G ^a,f   Bauchner, Howard ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c RAND CORPORATION   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e National Newborn Screening and Genetics Resource Center   (United States)

^f BOSTON MEDICAL CENTER   (United States)

Author keywords

Child; Newborn screening; Sickle cell disease; Sickle cell trait

Indexed keywords

ARTICLE; FOLLOW UP; GENETIC VARIABILITY; HEALTH CARE; HEALTH SURVEY; HUMAN; NEWBORN SCREENING; PRIORITY JOURNAL; SICKLE CELL ANEMIA; SICKLE CELL TRAIT;

ANEMIA, SICKLE CELL; COMMUNICATION; DATA COLLECTION; DISEASE NOTIFICATION; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SICKLE CELL TRAIT; STATE MEDICINE; UNITED STATES;

EID: 39749120447     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30160     Document Type: Article

References (23)

1. Bardakdijian-Michau J, Guilloud-Batailie M, Maier-Redelsperger M, Elion J, Girot R, Feingold J, Galacteros F, De Montalembert M. 2002. Decreased morbidity in homozygous sickle cell disease detected at birth. Hemoglobin 26:211-217.
2. Farrell MH, Certain LK, Farrell PM. 2001. Genetic counseling and risk communication services of newborn screening programs. Arch Pediatr Adolesc Med 155:120-126.
3. Franklin QJ, Wright SW, Kent LP. 1999. Splenic syndrome in sickle cell trait: Four case presentations and a review of the literature. Mil Med 164:230-233.
4. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, et al. 1986. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med 314:1593-1599.
5. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. 1987. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 317:781-787.
6. Kaye CI. Committee on Genetics. 2006. Introduction to the newborn screening fact sheets. Pediatrics 118:1304-1312.
7. Kemper AR, Uren RL, Moseley KL, Clark SJ. 2006. Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics 118:1836-1841.
8. Kerle KK, Runkle GP. 1996. Sickle cell trait and sudden death in athletes. JAMA 276:1472.
9. Kiryluk K, Jadoon A, Gupta M, Radhakrishnan J. 2006. Sickle cell trait and gross hematuria. Kidney Int 71:706-7710.
10. Laird L, Dezateux C, Anionwu EN. 1996. Fortnightly review: Neonatal screening for sickle cell disorders: What about the carrier infants? BMJ 313:407-411.
11. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. 1995. Improved survival in homozygous sickle cell disease: Lessons from a cohort study. BMJ 311:1600-1602.
12. Listernick R, Frisone L, Silverman BL. 1992. Delayed diagnosis of infants with abnormal neonatal screens. JAMA 267:1095-1099.
13. Martin JR, Hamilton BE, Sutton PD, et al. 2006. Final data for 2004.National vital statistics reports, Hyattsville, MD: National Center for Health Statistics. Vol. 55.
14. National Institutes of Health. 1987. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA 258:1205-1209.
15. National Newborn Screening and Genetics Resource Center. 2001. National newborn screening report - 2001. Austin, TX: Available at http://www2.uthscsa. edu/nnsis. Accessed May 18, 2007.
16. National Newborn Screening and Genetics Resource Center. 2007. National newborn screening report - 2007. Austin, TX: Available at http://www2.uthscsa. edu/nnsis. Accessed May 18, 2007.
17. Oliver S, Dezateux C, Kavanagh J, Lempert T, Stewart R. 2004. Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst Rev 18:CD003859.
18. Ross LF, Moon MR. 2000. Ethical issues in genetic testing of children. Arch Pediatr Adolesc Med 154:873-879.
19. Shafer FE, Lorey F, Cunningham GC, Klumpp GC, Vichinsky E, Lubin B. 1996. Newborn screening for sickle cell disease: 4 Years experience from California's newborn screening program. J Pediatr Hematol Oncol 18:36-41.
20. Sheikha A. 2005. Splenic syndrome in patients at high altitude with unrecognized sickle cell trait: Splenectomy is often unnecessary. Can J Surg 48:377-381.
21. Stoddard J, Farrell PM. 1997. State-to-state variations in newborn screening policies. Arch Pediatr Adolesc Med 151:561-564.
22. Therrell BL, Hannon WH. 2006. National evaluation of US newborn screening components. Ment Retard Dev Disabil Res Rev 12:236-245.
23. Therrell BL, Johnson A, Williams D. 2006. Status of newborn screening programs in the United States. Pediatrics 117:S212-S252.